Publication Results (495)

• «
• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• »

• Quality of cardiovascular disease care in Ontario, Canada: missed opportunities for prevention - a cross sectional study

  Liddy C, Singh J, Hogg W, Dahrouge S, Deri-Armstrong C, Russell G, Taljaard M, Akbari A, Wells G. BMC Cardiovasc Disord. 2012; 12:74. Epub 2012 Sep 12.

• Metformin use and all-cause and prostate cancer–specific mortality among men with diabetes

  Margel D, Urbach DR, Lipscombe LL, Bell CM, Kulkarni G, Austin PC, Fleshner N. J Clin Oncol. 2013; 31(25):3069-75. Epub 2013 Aug 5.

• The treatment of unrelated disorders in patients with chronic medical diseases

  Redelmeier DA, Siew H, Tan MA, Booth GL. N Engl J Med. 1998; 338(21):1516-20.

• Association between cardiovascular risk factors and aortic stenosis: the CANHEART aortic stenosis study

  Yan AT, Koh M, Chan KK, Guo H, Alter DA, Austin PC, Tu JV, Wijeysundera HC, Ko DT. J Am Coll Cardiol. 2017; 69(12):1523-32.

• Quantifying the impact of obesity category on major chronic diseases in Canada

  Jiang Y, Chen Y, Manuel D, Morrison H, Mao Y; Obesity Working Group. ScientificWorldJournal. 2007; 7:1211-21.

• Sedentary time and its association with risk for disease incidence, mortality, and hospitalization in adults: a systematic review and meta-analysis

  Biswas A, Oh PI, Faulkner GE, Bajaj RR, Silver MA, Mitchell MS, Alter DA. Ann Intern Med. 2015; 162(2):123-32. Epub 2015 Jan 20.

• Chronic disease prevalence in women and air pollution: a 30-year longitudinal cohort study

  To T, Zhu J, Villeneuve PJ, Simatovic J, Feldman L, Gao C, Williams D, Chen H, Weichenthal S, Wall C, Miller AB. Environ Int. 2015; 80:26-32. Epub 2015 Apr 6.

• Health care costs for prostate cancer patients receiving androgen deprivation therapy: treatment and adverse events

  Krahn MD, Bremner KE, Luo J, Alibhai SM. Curr Oncol. 2014; 21(3):e457-65.

• Self-monitoring of blood glucose levels: evaluating the impact of a policy of quantity limits on test-strip use and costs

  Gomes T, Martins D, Tadrous M, Paterson JM, Shah BR, Juurlink DN, Singh S, Mamdani MM. Can J Diabetes. 2016; 40(5):431-5. Epub 2016 May 17.

• Quality of primary care among individuals receiving treatment for opioid use disorder

  Spithoff S, Kiran T, Khuu W, Kahan M, Guan Q, Tadrous M, Leece P, Martins D, Gomes T. Can Fam Physician. 2019; 65(5):343-51. Epub 2019 May 1.

• Risk modification for diabetic patients. Are other risk factors treated as diligently as glycemia?

  Shah BR, Mamdani M, Jaakkimainen L, Hux JE. Can J Clin Pharmacol. 2004; 11(2):e239-44. Epub 2004 Nov 10.

• Cesarean delivery in relation to birth weight and gestational glucose tolerance: pathophysiology or practice style?

  Naylor CD, Sermer M, Chen E, Sykora K. JAMA. 1996; 275(15):1165-70.

• The relevance of subgroup-specific treatment effects: the Studies Of Left Ventricular Dysfunction (SOLVD) revisited

  Parker AB, Yusuf S, Naylor CD. Am Heart J. 2002; 144(6):941-7.

• Risk factors for cardiovascular disease in Canada

  Tanuseputro P, Manuel DG, Leung M, Nguyen K, Johansen H; Canadian Cardiovascular Outcomes Research Team. Can J Cardiol. 2003; 19(11):1249-59.

• Diabetic patients with prior specialist care have better glycaemic control than those with prior primary care

  Shah BR, Hux JE, Laupacis A, Mdcm BZ, Austin PC, van Walraven C. J Eval Clin Pract. 2005; 11(6):568-75.

• Medication use and survival in diabetic patients with kidney cancer: a population-based cohort study

  Nayan M, Macdonald EM, Juurlink DN, Austin PC, Finelli A, Kulkarni GS, Hamilton RJ; Canadian Drug Safety and Effectiveness Research Network (CDSERN). Pharmacol Res. 2016; 113(2016):468-74. Epub 2016 Sep 24.

• Cardiovascular risk factor management performance in Canada and the United States: a systematic review

  Alabousi M, Abdullah P, Alter DA, Booth GL, Hogg W, Ko DT, Manuel DG, Farkouh ME, Tu JV, Udell JA. Can J Cardiol. 2017; 33(3):393-404.

• Self-monitoring of blood glucose: impact of quantity limits in public drug formularies on provincial costs across Canada

  Knowles SR, Lee K, Paterson JM, Shah BR, Mamdani MM, Juurlink DN, Gomes T. Can J Diabetes. 2017; 41(2):138-42. Epub 2016 Dec 15.

• Risk factors for posterior compared to anterior ischemic stroke: an observational study of the Registry of the Canadian Stroke Network

  Subramanian G, Silva J, Silver FL, Fang J, Kapral MK, Oczkowski W, Gould L, O'Donnell MJ; Investigators of the Registry of the Canadian Stroke Network. Neuroepidemiology. 2009; 33(1):12-6. Epub 2009 Mar 20.

• Long-term safety and effectiveness of drug-eluting stents for the treatment of saphenous vein grafts disease: a population-based study

  Ko DT, Guo H, Wijeysundera HC, Zia MI, Dzavik V, Chu MW, Fremes SE, Cohen EA, Tu JV. JACC Cardiovasc Interv. 2011; 4(9):965-73.

• Ascertainment of chronic diseases using population health data: a comparison of health administrative data and patient self-report

  Muggah E, Graves E, Bennett C, Manuel DG. BMC Public Health. 2013; 13:16. Epub 2013 Jan 9.

• How does complementary private prescription drug insurance coverage affect seniors’ use of publicly funded medications?

  Allin S, Law MR, Laporte A. Health Policy. 2013; 110(2-3):147-55. Epub 2013 Mar 19.

• Pediatric insulin pump therapy: reflecting on the first 10 years of a universal funding program

  Shulman R, Miller FA, Stukel TA, Daneman D, Guttmann A. Healthc Q. 2017; 19(4):6-9.

• Estimating multimorbidity prevalence with the Canadian Chronic Disease Surveillance System

  Feely A, Lix LM, Reimer K. Health Promot Chronic Dis Prev Can. 2017; 37(7):215-22.

• Outcome of revascularization procedures for peripheral arterial occlusive disease in Ontario between 1991 and 1998: a population-based study

  Al-Omran M, Tu JV, Johnston KW, Mamdani MM, Kucey DS. J Vasc Surg. 2003; 38(2):279-88.

• Clinical inertia in response to inadequate glycemic control: do specialists differ from primary care physicians?

  Shah BR, Hux JE, Laupacis A, Zinman B, van Walraven C. Diabetes Care. 2005; 28(3):600-6.

• The impact of the Canadian Hypertension Education Program on antihypertensive prescribing trends

  Campbell NR, Tu K, Brant R, Duong-Hua M, McAlister FA; Canadian Hypertension Education Program Outcomes Research Task Force. Hypertension. 2006; 47(1):22-8. Epub 2005 Dec 12.

• Outpatient gatifloxacin therapy and dysglycemia in older adults

  Park-Wyllie LY, Juurlink DN, Kopp A, Shah BR, Stukel TA, Stumpo C, Dresser L, Low DE, Mamdani MM. N Engl J Med. 2006; 354(13):1352-61. Epub 2006 Mar 1.

• The relationship between need and capacity for multidisciplinary cardiovascular risk-reduction programs in Ontario

  Candido E, Richards JA, Oh P, Suskin N, Arthur HM, Fair T, Alter DA. Can J Cardiol. 2011; 27(2):200-7. Epub 2011 Mar 1.

• Co-morbid non-communicable diseases and associated health service use in African and Caribbean immigrants with HIV

  Masindi KI, Jembere N, Kendall CE, Burchell AN, Bayoumi AM, Loutfy M, Raboud J, Rourke SB, Luyombya H, Antoniou T. J Immigr Minor Health. 2018; 20(3):536-45. Epub 2017 Dec 5.

• Quantifying comorbidity in individuals with chronic obstructive pulmonary disease: a population study

  Gershon AS, Mecredy GC, Guan J, Victor JC, Goldstein R, To T. Eur Respir J. 2015; 45(1):51-9. Epub 2014 Aug 20.

• Case selection for statins was similar in two Canadian provinces: BC and Ontario

  Paterson JM, Carney G, Anderson GM, Bassett K, Naglie G, Laupacis A; BC-Ontario Pharmacosurveillance for Decision-making Collaborative. J Clin Epidemiol. 2007; 60(1):73-8. Epub 2006 Sep 7.

• July 2018

  Report

  • Health Care Cost of Smoking in Ontario, 2003 to 2041

  Infographics / Quote Graphics

  • Beyond the grey tsunami: a cross-sectional population-based study of multimorbidity in Ontario
  • Association of frailty and long‐term survival in patients undergoing coronary artery bypass grafting
  • Place of care trajectories in the last two weeks of life: a population-based cohort study of Ontario decedents
  • Diabetes transition care and adverse events: a population-based cohort study in Ontario, Canada

  ICES in the News

  • Development and validation of a cardiovascular disease risk prediction model using population health surveys: the Cardiovascular Disease Population Risk Tool (CVDPoRT)
  • Sex differences in outcomes of heart failure in an ambulatory, population-based cohort from 2009 to 2013
  • Adverse effect of long work hours on incident diabetes in 7065 Ontario workers followed for 12 years

  You may also be interested in...

  • The characteristics and outcomes of patients who make an emergency department visit for hypertension after use of a home or pharmacy blood pressure device
  • Case mix, patterns of care, and inpatient outcomes among Ontario kidney transplant centers: a population-based study
  • Thiazide diuretic dose and risk of kidney stones in older adults: a retrospective cohort study
  • Second-generation anti-depressants and risk of new-onset seizures in the elderly
  • Prenatal biochemical screening and long term risk of maternal cardiovascular disease: population based cohort study

• Trends in antihyperglycemic medication prescriptions and hypoglycemia in older adults: 2002-2013

  Clemens KK, Shariff S, Liu K, Hramiak I, Mahon JL, McArthur E, Garg AX. PLoS One. 2015; 10(9):e0137596.

• Prevalence and correlates of renal disease in older lithium users: a population-based study

  Rej S, Shulman K, Herrmann N, Harel Z, Fischer HD, Fung K, Gruneir A. Am J Geriatr Psychiatry. 2014; 22(11):1075-82. Epub 2014 Feb 2.

• Universal drug coverage and income-related disparities in glycaemic control

  Branfield Day L, Austin PC, Shah BR. Diabet Med. 2019 Jun; 14 [Epub ahead of print]. DOI: 10.1111/dme.14051.

• July 2019

  Infographics

  • Changing rates of self-harm and mental disorders by sex in youths presenting to Ontario emergency departments: repeated cross-sectional study
  • Same-day discharge after elective percutaneous coronary interventions in Ontario, Canada
  • Management of sleep disorders in community-dwelling older women and men at the time of diagnosis
  • The risk of cardiovascular events on cannabis’ highest day

  ICES in the News

  • Interaction between neighborhood walkability and traffic-related air pollution on hypertension and diabetes: the CANHEART cohort
  • Introduction of anti-TNF therapy has not yielded expected declines in hospitalisation and intestinal resection rates in inflammatory bowel diseases: a population-based interrupted time series study
  • Geographic Variation in Primary Care Need, Service Use and Providers in Ontario, 2015/16

  You may also be interested in...

  • Risk of hospitalization for serious adverse gastrointestinal events associated with sodium polystyrene sulfonate use in patients of advanced age
  • Primary care performance of alternatively licenced physicians in Ontario, Canada: a cross-sectional study using administrative data
  • Adherence to predefined dietary patterns and risk of developing type 2 diabetes in the Canadian adult population
  • The urine culturing cascade: variation in nursing home urine culturing and association with antibiotic use and C. difficile infection
  • A challenge to all. A primer on inter-country differences of high-need, high-cost patients
  • Suicide and self-harm in recent immigrants in Ontario, Canada: a population-based study

• January 2017

  Infographics

  • Marking 25 years of research impact
  • Living near major roads and the incidence of dementia, Parkinson's disease, and multiple sclerosis: a population-based cohort study
  • Inadequate screening for retinopathy among recent immigrants with type 2 diabetes despite universal health care: a population-based study

  Research video

  • Paul Kurdyak on ADHD rates and medication trends in Ontario

  ICES in the News

  • Variation in access to kidney transplantation across renal programs in Ontario, Canada

  You may also be interested in....

  • Using the electronic medical record to identify patients at high risk for frequent ED visits and high system costs
  • Long-term clinical outcomes and predictors for survivors of out-of-hospital cardiac arrest
  • Effect of prepublication results on trends in prescribing of antihypertensive medication
  • Accounting for competing risks in randomized controlled trials: a review and recommendations for improvement
  • Outcomes of women and men with acute coronary syndrome treated with and without percutaneous coronary revascularization

• November 2016

  • Risk of death from heart disease or cancer rises with either high or low HDL cholesterol
  • No worse outcomes seen after limit set on reimbursed diabetes test strips
  • ICES research video series: Tara Kiran on barriers to primary care reform for vulnerable patients
  • Gap closing on male, female life expectancy in Canada
  • More than 600 Ontarians died of opioid-related causes in 2013 with wide variation across the province
  • Study finds risk of hemorrhage with combination of two common statins and stroke prevention drug
  • Ontario Stroke Evaluation Report 2016: A Focus on Stroke Rehabilitation
  • Variability in antibiotic use across Ontario acute care hospitals
  • Recent temporal changes in atherosclerotic cardiovascular diseases in Ontario: clinical and health systems impact
  • Predictors of and trends in high-intensity end-of-life care among children with cancer: a population-based study using health services data
  • Prevalence, recurrence, and incidence of current depressive symptoms among people living with HIV in Ontario, Canada: results from the Ontario HIV Treatment Network Cohort Study

• ICES–Métis Nation of Ontario Reports on Chronic Diseases

  Diabetes: Shah BR, Cauch-Dudek K, Wu CF. Cardiovascular Disease: Atzema CL, Kapral M, Klein-Geltink J, Asllani E. Cancer: Klein-Geltink J, Saskin R, Manno M, Urbach DR, Henry DA. Repiratory Disease: Klein-Geltink J, Khan S, Cascagnette P, Gershon G, To T, Crighton E, Henry DA, Pigeau L, MacQuarrie J, Allard Y, Burns B.  March 2012

• «
• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• »